These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15146371)

  • 1. The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations.
    Stumvoll M; Fritsche A; t'Hart LM; Machann J; Thamer C; Tschritter O; Van Haeften TW; Jacob S; Dekker JM; Maassen JA; Machicao F; Schick F; Heine RJ; Häring H
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):253-7. PubMed ID: 15146371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.
    Ek J; Andersen G; Urhammer SA; Gaede PH; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
    Diabetologia; 2001 Dec; 44(12):2220-6. PubMed ID: 11793024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the peroxisome proliferator-activated receptor-gamma co-activator-1 Gly482Ser variant on features of the metabolic syndrome.
    Vohl MC; Houde A; Lebel S; Hould FS; Marceau P
    Mol Genet Metab; 2005; 86(1-2):300-6. PubMed ID: 16122961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects.
    Fanelli M; Filippi E; Sentinelli F; Romeo S; Fallarino M; Buzzetti R; Leonetti F; Baroni MG
    Dis Markers; 2005; 21(4):175-80. PubMed ID: 16403952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases.
    Horiki M; Ikegami H; Fujisawa T; Kawabata Y; Ono M; Nishino M; Shimamoto K; Ogihara T
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S63-7. PubMed ID: 15563983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
    Wang C; Zhai F; Chi Y; Wang G
    Wei Sheng Yan Jiu; 2004 May; 33(3):317-20. PubMed ID: 15211802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins.
    Ling C; Poulsen P; Carlsson E; Ridderstråle M; Almgren P; Wojtaszewski J; Beck-Nielsen H; Groop L; Vaag A
    J Clin Invest; 2004 Nov; 114(10):1518-26. PubMed ID: 15546003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
    Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
    Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians.
    Muller YL; Bogardus C; Pedersen O; Baier L
    Diabetes; 2003 Mar; 52(3):895-8. PubMed ID: 12606537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia.
    Asmann YW; Stump CS; Short KR; Coenen-Schimke JM; Guo Z; Bigelow ML; Nair KS
    Diabetes; 2006 Dec; 55(12):3309-19. PubMed ID: 17130474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.
    Ambye L; Rasmussen S; Fenger M; Jørgensen T; Borch-Johnsen K; Madsbad S; Urhammer SA
    Diabetes Res Clin Pract; 2005 Feb; 67(2):175-9. PubMed ID: 15649578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of genetic variations in HHEX gene on insulin metabolism in the German MESYBEPO cohort.
    Pivovarova O; Nikiforova VJ; Pfeiffer AF; Rudovich N
    Diabetes Metab Res Rev; 2009 Feb; 25(2):156-62. PubMed ID: 19117022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise.
    Yokoyama H; Mori K; Emoto M; Araki T; Teramura M; Mochizuki K; Tashiro T; Motozuka K; Inoue Y; Nishizawa Y
    Diabetes Obes Metab; 2008 May; 10(5):400-7. PubMed ID: 18410564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids.
    Thamer C; Tschritter O; Haap M; Shirkavand F; Machann J; Fritsche A; Schick F; Häring H; Stumvoll M
    Horm Metab Res; 2005 Apr; 37(4):246-51. PubMed ID: 15952086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle neuronal nitric oxide synthase micro protein is reduced in people with impaired glucose homeostasis and is not normalized by exercise training.
    Bradley SJ; Kingwell BA; Canny BJ; McConell GK
    Metabolism; 2007 Oct; 56(10):1405-11. PubMed ID: 17884453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition.
    Silbernagel G; Stefan N; Hoffmann MM; Machicao-Arano F; Machann J; Schick F; Winkelmann BR; Boehm BO; Häring HU; Fritsche A; März W
    Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):113-8. PubMed ID: 18726867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity.
    Andersen G; Wegner L; Yanagisawa K; Rose CS; Lin J; Glümer C; Drivsholm T; Borch-Johnsen K; Jørgensen T; Hansen T; Spiegelman BM; Pedersen O
    J Med Genet; 2005 May; 42(5):402-7. PubMed ID: 15863669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of relationships between the GLUT10 Ala206Thr polymorphism and impaired insulin secretion.
    Rose CS; Andersen G; Hamid YH; Glümer C; Drivsholm T; Borch-Johnsen K; Jørgensen T; Pedersen O; Hansen T
    Diabet Med; 2005 Jul; 22(7):946-9. PubMed ID: 15975113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic characteristics of soleus muscle in relation to insulin action in the offspring of hypertensive parents.
    Kratochvílová S; Vyhnanovská P; Vlasáková Z; Hájek M; Skibová J; Pelikánová T
    Metabolism; 2006 Oct; 55(10):1388-96. PubMed ID: 16979411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.